Benzocaine Orally Disintegrating Tablet (ODT) made by direct compression
Formulation Guideline

Benzocaine Orally Disintegrating Tablet (ODT) made by direct compression

Benzocaine formulation demonstrating the excellent properties of PEARLITOL® Flash co-process mannitol starch as directly compressible excipient for orally disintegrating tablets.

Objective

Realize a formulation for orally disintegrating tablet made by direct compression. The tablet must present quick disintegration time and offer good stability of the API.

 

Formula

Ingredient

Functionality of the ingredient

mg/tablet
(Total weight: 500mg)

% by weight

Benzocaine

Active Ingredient

30

6

PEARLITOL® Flash

Direct compression filler-binder with disintegrant benefits

462.5

92.5

Magnesium stearate

Lubricant

7.5

1.5

 

Method

  1. In a mixer, mix the ingredients for 10 minutes.

  2. Compress the powder with a 10 mm concave punch.

Additional comments

Hardness 100 N
Friability test Passed
Disintegration time 60s (in 200 mL of water)
 API stability Chemical inertness of PEARLITOL® Flash toward benzocaine, superior humidity stability in comparison to other ODT platforms (see reference article for more detail)
 Tablet mass 500 mg
PEARLITOL® Flash is a co-processed mannitol starch specifically designed for direct compression with disintegrating properties. Distinctive physicochemical properties of co-processed mannitol starch make it an excellent excipient for orally disintegrating formulations as it gives short disintegration time together with high API stability. PEARLITOL® Flash is low hygroscopic and chemically stable. It brings a pleasant texture and a slightly sweet taste. PEARLITOL® Flash is EP/USP-NF/JP compliant.
 

 

Reference

Köllmer, M., Popescu, C., Manda, P., Zhou, L., Gemeinhart, R. A., Stability of Benzocaine Formulated in Commercial Oral Disintegrating Tablet Platforms, AAPS PharmSciTech 14, 1333-1340 (2013)

Disclaimer

This formula is a guideline for recommended use of our products; it does not imply consent to their use in violation of existing patent(s). 
These details are for information only, and we believe them to be reliable.

Request a Document

Entering your details below will send your query to the relevant team for a swift and helpful response. We will not use your details for anything other than replying to your query.

Product Details

Your Details


By giving your consent, you confirm that you have read the relevant Privacy Notice available here.

* Required fields

Request A Document

{Market}

Submit > {Product} > {Usage Country}